PL2726635T3 - Multigenowy prognostyczny test na raka płuc - Google Patents

Multigenowy prognostyczny test na raka płuc

Info

Publication number
PL2726635T3
PL2726635T3 PL12807429T PL12807429T PL2726635T3 PL 2726635 T3 PL2726635 T3 PL 2726635T3 PL 12807429 T PL12807429 T PL 12807429T PL 12807429 T PL12807429 T PL 12807429T PL 2726635 T3 PL2726635 T3 PL 2726635T3
Authority
PL
Poland
Prior art keywords
multigenic
lung cancer
cancer test
prognostic
prognostic lung
Prior art date
Application number
PL12807429T
Other languages
English (en)
Inventor
Michael J. Mann
David M. Jablons
Johannes KRATZ
David Berryman
Original Assignee
The Regents Of The University Of California
Encore Clinical, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Regents Of The University Of California, Encore Clinical, Inc. filed Critical The Regents Of The University Of California
Publication of PL2726635T3 publication Critical patent/PL2726635T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL12807429T 2011-07-01 2012-06-29 Multigenowy prognostyczny test na raka płuc PL2726635T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161504063P 2011-07-01 2011-07-01
US201161504193P 2011-07-02 2011-07-02
PCT/US2012/045139 WO2013006503A1 (en) 2011-07-01 2012-06-29 Multigene prognostic assay for lung cancer
EP12807429.1A EP2726635B1 (en) 2011-07-01 2012-06-29 Multigene prognostic assay for lung cancer

Publications (1)

Publication Number Publication Date
PL2726635T3 true PL2726635T3 (pl) 2018-04-30

Family

ID=47437384

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12807429T PL2726635T3 (pl) 2011-07-01 2012-06-29 Multigenowy prognostyczny test na raka płuc

Country Status (9)

Country Link
US (1) US9476098B2 (pl)
EP (1) EP2726635B1 (pl)
CN (1) CN103998622A (pl)
AU (1) AU2012279173B2 (pl)
DK (1) DK2726635T3 (pl)
ES (1) ES2658921T3 (pl)
HU (1) HUE036585T2 (pl)
PL (1) PL2726635T3 (pl)
WO (1) WO2013006503A1 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140147855A1 (en) * 2011-07-01 2014-05-29 Pinpoint Genomics, Inc. Method for Extracting RNA from Fixed Embedded Tissue
EP2726635B1 (en) 2011-07-01 2017-11-08 The Regents of The University of California Multigene prognostic assay for lung cancer
US20160019337A1 (en) * 2013-03-15 2016-01-21 Htg Molecular Diagnostics, Inc. Subtyping lung cancers
US9526611B2 (en) 2013-10-29 2016-12-27 Tendyne Holdings, Inc. Apparatus and methods for delivery of transcatheter prosthetic valves
CN105985422A (zh) * 2015-01-30 2016-10-05 天津奥维亚生物技术有限公司 一种人sh3bgr多肽及其抗体制备方法
AU2016248314B2 (en) 2015-04-16 2020-05-21 Tendyne Holdings, Inc. Apparatus and methods for delivery, repositioning, and retrieval of transcatheter prosthetic valves
CN108139381A (zh) 2015-06-26 2018-06-08 百奥马克癌症系统公司 肺癌检测方法
CN105929164B (zh) * 2016-06-30 2018-06-26 四川大学华西医院 一种肺癌筛查试剂盒
CN105954517B (zh) * 2016-06-30 2018-09-18 四川大学华西医院 一种肺癌筛查试剂盒
CN106119405B (zh) * 2016-08-31 2019-11-12 广州万德基因医学科技有限公司 一种肺癌的预后标记物、使用该标记预测肺癌预后的方法及应用
KR20250047324A (ko) 2017-08-07 2025-04-03 더 존스 홉킨스 유니버시티 암을 평가하고 치료하기 위한 방법 및 재료
CA3124430A1 (en) * 2018-12-21 2020-06-25 Biomark Cancer Systems Inc. Method of detecting lung cancer
CN109859801B (zh) * 2019-02-14 2023-09-19 辽宁省肿瘤医院 一种含有七个基因作为生物标志物预测肺鳞癌预后的模型及建立方法
EP3831343B1 (en) 2019-12-05 2024-01-31 Tendyne Holdings, Inc. Braided anchor for mitral valve
US11648114B2 (en) 2019-12-20 2023-05-16 Tendyne Holdings, Inc. Distally loaded sheath and loading funnel
US11951002B2 (en) 2020-03-30 2024-04-09 Tendyne Holdings, Inc. Apparatus and methods for valve and tether fixation
CN111564177B (zh) * 2020-05-22 2023-03-31 四川大学华西医院 基于dna甲基化的早期非小细胞肺癌复发模型构建方法
CN112037863B (zh) * 2020-08-26 2022-06-21 南京医科大学 一种早期nsclc预后预测系统
CN114438188A (zh) * 2021-11-29 2022-05-06 中国辐射防护研究院 高甲基化CDK2AP1基因作为α辐射损伤预测的分子标志物的用途
CN114660291B (zh) * 2022-04-26 2024-11-12 山东大学齐鲁医院 一种膀胱癌预后标志物、预后评估系统及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6019944A (en) 1992-05-21 2000-02-01 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US7955800B2 (en) * 2002-06-25 2011-06-07 Advpharma Inc. Metastasis-associated gene profiling for identification of tumor tissue, subtyping, and prediction of prognosis of patients
EP2728018B1 (en) 2007-06-01 2016-11-23 The Regents of The University of California Multigene prognostic assay for lung cancer
AU2011223789A1 (en) * 2010-03-01 2012-09-20 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
EP2726635B1 (en) 2011-07-01 2017-11-08 The Regents of The University of California Multigene prognostic assay for lung cancer

Also Published As

Publication number Publication date
US20130059747A1 (en) 2013-03-07
US9476098B2 (en) 2016-10-25
EP2726635A1 (en) 2014-05-07
CN103998622A (zh) 2014-08-20
EP2726635A4 (en) 2015-02-18
AU2012279173B2 (en) 2016-06-16
WO2013006503A1 (en) 2013-01-10
DK2726635T3 (en) 2018-02-12
AU2012279173A1 (en) 2013-05-09
ES2658921T3 (es) 2018-03-12
HUE036585T2 (hu) 2018-07-30
EP2726635B1 (en) 2017-11-08

Similar Documents

Publication Publication Date Title
HUE036585T2 (hu) Sokgénes prognosztizáló ASSAY tüdõrákra
IL229319A0 (en) Biomarkers for lung cancer
IL252163A0 (en) Lung cancer biomarkers and uses thereof
DK2761305T3 (da) Forenet reagensstrimmel
EP2739754A4 (en) MICRO-RNA biomarkers
LT2804617T (lt) Didelio giminingumo sirp-alfa reagentai
IL229621A0 (en) Multi-application environment
IL221719A (en) Biomarkers for theranostics
EP2841603A4 (en) METHODS OF ASSESSING THE STATUS OF LUNG CANCER
DK2761553T3 (da) Betalingssystem
UA23775S (uk) Автомобіль
UA22785S (uk) Автомобіль
EP2625292A4 (en) KREBSBIOMARKER
ME03751B (me) Antitela usmerena na beta-amiloid
EP2748608A4 (en) LUNG CANCER TESTS
IL227956A0 (en) Terahertz modulator
UA24057S (uk) Автомобіль
EP2828282A4 (en) BIOMARKERS
IL228636A0 (en) Biomarkers for predicting sensitivity to cancer treatments
UA24289S (uk) Автомобіль
UA23375S (uk) Автомобіль
UA23365S (uk) Автомобіль
FR2971421B1 (fr) Composition biphase
EP2703014A4 (en) SYNTHETIC ENAMEL MATERIAL
UA23272S (uk) Автомобіль